European Journal of Nuclear Medicine and Molecular Imaging - Featured content on Alpha Particles Therapy

Please also check the respective themed section on issue level (see Issue 1/2022) at https://link.springer.com/journal/259/volumes-and-issues. Here you will find all topical special issues or themed sections published so far.

King, A.P., Lin, F.I. & Escorcia, F.E.

Why bother with alpha particles?

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05431-y

Sgouros, G., Frey, E., Du, Y. et al.

Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05583-x

Sathekge, M.M., Bruchertseifer, F., Vorster, M. et al.

Global experience with PSMA-based alpha therapy in prostate cancer.

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05434-9 and https://doi.org/10.1007/s00259-021-05531-9

Jadvar, H., Colletti, P.M.

Targeted α-therapy in non-prostate malignancies.

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05405-0

Kratochwil, C., Apostolidis, L., Rathke, H. et al.

Dosing ²²⁵Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05474-1

Hong, J.A., Brechbiel, M., Buchsbaum, J. et al.

National Cancer Institute support for targeted alpha-emitter therapy

Eur J Nucl Med Mol Imaging (2021)

https://doi.org/10.1007/s00259-021-05503-z